Ferrer, M.D.; Reynés, C.; Monserrat-Mesquida, M.; Quetglas-Llabrés, M.; Bouzas, C.; GarcÃa, S.; Mateos, D.; Casares, M.; Gómez, C.; Ugarriza, L.;
et al. Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages. Antioxidants 2023, 12, 711.
https://doi.org/10.3390/antiox12030711
AMA Style
Ferrer MD, Reynés C, Monserrat-Mesquida M, Quetglas-Llabrés M, Bouzas C, GarcÃa S, Mateos D, Casares M, Gómez C, Ugarriza L,
et al. Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages. Antioxidants. 2023; 12(3):711.
https://doi.org/10.3390/antiox12030711
Chicago/Turabian Style
Ferrer, Miguel D., Clara Reynés, Margalida Monserrat-Mesquida, Magdalena Quetglas-Llabrés, Cristina Bouzas, Silvia GarcÃa, David Mateos, Miguel Casares, Cristina Gómez, LucÃa Ugarriza,
and et al. 2023. "Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages" Antioxidants 12, no. 3: 711.
https://doi.org/10.3390/antiox12030711
APA Style
Ferrer, M. D., Reynés, C., Monserrat-Mesquida, M., Quetglas-Llabrés, M., Bouzas, C., GarcÃa, S., Mateos, D., Casares, M., Gómez, C., Ugarriza, L., Tur, J. A., Sureda, A., & Pons, A.
(2023). Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages. Antioxidants, 12(3), 711.
https://doi.org/10.3390/antiox12030711